KR102062645B1 - 생물학적 물질용 안정화 조성물 - Google Patents

생물학적 물질용 안정화 조성물 Download PDF

Info

Publication number
KR102062645B1
KR102062645B1 KR1020147029648A KR20147029648A KR102062645B1 KR 102062645 B1 KR102062645 B1 KR 102062645B1 KR 1020147029648 A KR1020147029648 A KR 1020147029648A KR 20147029648 A KR20147029648 A KR 20147029648A KR 102062645 B1 KR102062645 B1 KR 102062645B1
Authority
KR
South Korea
Prior art keywords
composition
formulation
drying
dry
hydrolyzed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147029648A
Other languages
English (en)
Korean (ko)
Other versions
KR20140135845A (ko
Inventor
모티 하렐
퀴옹 탕
트리샤 라이스
킴벌리 제닝즈
브라이언 카펜터
로저 드류스
엘리자베스 라디트시스
Original Assignee
어드밴스드 바이오뉴트리션 코프.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 어드밴스드 바이오뉴트리션 코프. filed Critical 어드밴스드 바이오뉴트리션 코프.
Publication of KR20140135845A publication Critical patent/KR20140135845A/ko
Application granted granted Critical
Publication of KR102062645B1 publication Critical patent/KR102062645B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/30—Puffing or expanding
    • A23P30/32—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020147029648A 2012-03-23 2013-03-22 생물학적 물질용 안정화 조성물 Expired - Fee Related KR102062645B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261614994P 2012-03-23 2012-03-23
US61/614,994 2012-03-23
US201261642094P 2012-05-03 2012-05-03
US61/642,094 2012-05-03
US201261646337P 2012-05-13 2012-05-13
US61/646,337 2012-05-13
PCT/US2013/033505 WO2013142792A1 (en) 2012-03-23 2013-03-22 Stabilizing composition for biological materials

Publications (2)

Publication Number Publication Date
KR20140135845A KR20140135845A (ko) 2014-11-26
KR102062645B1 true KR102062645B1 (ko) 2020-01-06

Family

ID=49223367

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147029648A Expired - Fee Related KR102062645B1 (ko) 2012-03-23 2013-03-22 생물학적 물질용 안정화 조성물

Country Status (18)

Country Link
EP (1) EP2827905B1 (enExample)
JP (1) JP6229188B2 (enExample)
KR (1) KR102062645B1 (enExample)
CN (2) CN104244985A (enExample)
AR (1) AR093204A1 (enExample)
AU (1) AU2013234931B2 (enExample)
BR (1) BR112014023234B1 (enExample)
CA (1) CA2866889C (enExample)
CL (1) CL2014002506A1 (enExample)
ES (1) ES3016483T3 (enExample)
IN (1) IN2014DN08599A (enExample)
MX (1) MX356072B (enExample)
MY (1) MY178686A (enExample)
NZ (1) NZ628912A (enExample)
PH (1) PH12014502092B1 (enExample)
RU (1) RU2666601C2 (enExample)
SG (1) SG11201405478VA (enExample)
WO (1) WO2013142792A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255583A1 (en) * 2013-03-06 2014-09-11 Sunny Delight Beverages Company Protein suspension as a beverage opacifier system
MY195765A (en) 2013-10-25 2023-02-10 Nch Corp Delivery System and Probiotic Composition for Animals and Plants
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
JP6731416B2 (ja) * 2015-02-11 2020-07-29 プレヴテック マイクロビア インコーポレイテッド 生きている大腸菌を埋め込むための改良された乾燥マトリクス、その製造方法及びその使用
KR102685914B1 (ko) * 2015-07-29 2024-07-16 어드밴스드 바이오뉴트리션 코프. 특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물
MX395197B (es) * 2015-12-04 2025-03-19 Advanced Bionutrition Corp Composiciones secas estables que no tienen o contienen pocos azucares.
WO2017103742A1 (en) * 2015-12-18 2017-06-22 Nestec Sa Hydration for animals
FR3045384B1 (fr) * 2015-12-18 2020-02-07 Institut National De La Recherche Agronomique Composition lyophilisee pour la conservation de microbiote dans son ecosysteme
CN105504050A (zh) * 2016-03-03 2016-04-20 河南欧普生物科技有限公司 一种抗安卡拉病毒鸡卵黄抗体的制备方法
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
CN108884434B (zh) 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
RU2749883C2 (ru) * 2016-06-14 2021-06-18 Эланко Кэнэда Лимитед Гранулированный корм для животных, содержащий кормовую добавку, способ его получения и применения
PL3476226T3 (pl) 2016-06-24 2024-08-19 Yessinergy Holding S/A Kompozycja immunomodulująca i promująca wzrost oraz kontrolująca niepożądane bakterie mikrobioty jelitowej i jej zastosowanie
KR101766430B1 (ko) 2016-10-28 2017-08-08 주식회사 삼양사 올리고당을 함유하는 알룰로오스 시럽 및 그 제조방법
CN106819418A (zh) * 2017-03-27 2017-06-13 张军军 一种超高脂饲料及其制备方法
US10323226B2 (en) * 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
WO2020007906A1 (en) * 2018-07-04 2020-01-09 Chr. Hansen A/S Aqueous topical compositions comprising viable probiotic bacteria
WO2020007931A1 (en) 2018-07-04 2020-01-09 Chr. Hansen A/S Topical compositions comprising viable probiotic bacteria
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
CA3117725A1 (en) * 2018-10-26 2020-04-30 Danisco Us Inc Stable microbial composition and drying process
EP3891112A4 (en) * 2018-12-07 2022-11-09 Pivot Bio, Inc. STABILITY-ENHANCED POLYMERIC COMPOSITIONS FOR NITROGEN-FIXING MICROBIAL PRODUCTS
WO2020130770A1 (es) * 2018-12-19 2020-06-25 Ajtzakbio S.A.P.I. De C.V. Composición probiótica de alto valor sin necesidad de cadena de frio, desarrollada para reducir el impacto ambiental, aumentar la producción y mejorar la supervivencia de larvas de camarón
US20220389369A1 (en) * 2019-09-16 2022-12-08 Vedanta Biosciences, Inc. Methods and compositions for preserving bacteria
MX2022004950A (es) * 2019-10-22 2022-05-16 Massachusetts Inst Technology Composiciones a base de biomateriales para entregar microbios que promueven el crecimiento de las plantas.
CN110923145B (zh) * 2019-12-16 2021-07-20 天康制药(苏州)有限公司 支原体的冻干保护剂与冻干支原体及其制备方法
WO2021159068A1 (en) 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
US20230080017A1 (en) * 2020-02-19 2023-03-16 Zantebio Limited Coated microcapsules and methods for the production thereof
RU2736064C1 (ru) * 2020-04-03 2020-11-11 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Защитная среда для стабилизации клеток возбудителя туляремии в процессе приготовления и хранения сухих препаратов
RU2746022C1 (ru) * 2020-04-03 2021-04-06 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Способ стабилизации бактериальных клеток чумного микроба перед сублимационным высушиванием
CA3172321A1 (en) 2020-05-01 2021-11-04 Farzaneh REZAEI Stable liquid formulations for nitrogen-fixing microorganisms
JP2022102198A (ja) * 2020-12-25 2022-07-07 ライオン株式会社 内服固形剤
US20240041951A1 (en) * 2020-12-25 2024-02-08 Hayashibara Co., Ltd. Method for improving productivity in livestock and/or poultry and method for improving intestinal flora in livestock and/or poultry
JP2024508212A (ja) * 2021-02-10 2024-02-26 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状組成物（ｉ）
JP2024506466A (ja) * 2021-02-10 2024-02-14 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状組成物（ｉｉ）
CN112843328B (zh) * 2021-02-25 2022-05-13 山东大学 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法
CN113621519B (zh) * 2021-08-11 2023-07-18 河南农业大学 一种复合酵母冻干保护剂
CN119255821A (zh) * 2021-08-25 2025-01-03 奥古斯汀·T·兹维纳瓦什 微生物组递送平台
WO2023050121A1 (zh) * 2021-09-29 2023-04-06 中国科学院过程工程研究所 一种基于氨基酸的玻璃
CN114196579A (zh) * 2021-12-13 2022-03-18 张峰 一种建筑通风工程用的甲醛微生物净化器
EP4512388A1 (en) * 2022-04-21 2025-02-26 Obshchestvo S Ogranichennoj Otvetstvennostyu «Kinetik-Farm» Means for intravaginal delivery of an active ingredient and method for producing and using same
CN116040604B (zh) * 2022-12-21 2025-04-29 天津华电南疆热电有限公司 一种用于微生物培养的碳源材料及其制备方法
CN116694581A (zh) * 2023-05-24 2023-09-05 华南农业大学 哈维氏弧菌噬菌体v-ydf132的冻干保护剂及其保藏方法
CN117256857B (zh) * 2023-07-24 2025-12-02 浙江大学 一种用于制备鱼油微胶囊的复合壁材及其制备方法与应用
WO2025055959A1 (en) * 2023-09-12 2025-03-20 Bing Biotech Limited Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
CN117247305A (zh) * 2023-09-16 2023-12-19 鲁东大学 一种促进植物根系生长的水凝胶及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20120039956A1 (en) * 2010-08-13 2012-02-16 Moti Harel Dry storage stabilizing composition for biological materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212045B1 (en) * 1999-08-24 2016-08-17 Abic Biological Laboratories Ltd. A vaccine composition and method of using the same
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
CZ301813B6 (cs) 2000-06-27 2010-06-30 F. Hoffmann-La Roche Ag Zpusob prípravy farmaceutické kompozice
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
WO2003087327A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
US20060105938A1 (en) * 2002-09-16 2006-05-18 Andries Siemensma Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
JP5214464B2 (ja) * 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
WO2008076975A1 (en) * 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
BRPI0820584A2 (pt) * 2007-12-20 2015-07-14 Abbott Lab Pó nutricional estável
AU2009306497B2 (en) * 2008-10-20 2015-01-29 Société des Produits Nestlé S.A. Nutritional composition with anti-regurgitation properties
TWI468157B (zh) * 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法，進行該方法的系統及包含該錠劑的包裝物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20120039956A1 (en) * 2010-08-13 2012-02-16 Moti Harel Dry storage stabilizing composition for biological materials

Also Published As

Publication number Publication date
AR093204A1 (es) 2015-05-27
AU2013234931A1 (en) 2014-09-18
EP2827905B1 (en) 2025-03-12
CA2866889A1 (en) 2013-09-26
MY178686A (en) 2020-10-20
EP2827905C0 (en) 2025-03-12
AU2013234931A2 (en) 2014-12-04
BR112014023234A2 (pt) 2017-06-20
MX2014011122A (es) 2014-12-05
JP6229188B2 (ja) 2017-11-15
CL2014002506A1 (es) 2015-01-09
EP2827905A1 (en) 2015-01-28
WO2013142792A1 (en) 2013-09-26
CA2866889C (en) 2021-08-31
EP2827905A4 (en) 2015-05-06
NZ628912A (en) 2016-06-24
ES3016483T3 (en) 2025-05-09
RU2014136089A (ru) 2016-05-20
BR112014023234A8 (pt) 2018-01-16
RU2666601C2 (ru) 2018-09-11
CN114601849A (zh) 2022-06-10
KR20140135845A (ko) 2014-11-26
CN104244985A (zh) 2014-12-24
JP2015517985A (ja) 2015-06-25
BR112014023234B1 (pt) 2020-12-08
PH12014502092B1 (en) 2019-11-20
SG11201405478VA (en) 2014-11-27
AU2013234931B2 (en) 2017-12-07
MX356072B (es) 2018-05-14
PH12014502092A1 (en) 2014-11-24
IN2014DN08599A (enExample) 2015-05-22

Similar Documents

Publication Publication Date Title
KR102062645B1 (ko) 생물학적 물질용 안정화 조성물
US10575545B2 (en) Stabilizing composition for biological materials
JP5886763B2 (ja) 生物活性物質を含む乾燥ガラス状組成物
CN103140145B (zh) 用于生物材料的干的贮存稳定用组合物
EP3328215B1 (en) Stable dry probiotic compositions for special dietary uses
US20190045704A1 (en) Stabilizing methods for coating seeds with biological materials
KR102754888B1 (ko) 당을 전혀 또는 거의 함유하지 않은 안정한 건조 조성물

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20231231

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20231231